# Italy Structural Heart Devices Market

> Italy Structural Heart Devices Market Research Report: Size, Share, Trend Analysis By Types (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.69%
- **2024:** $ 23.1 Million
- **2025:** $ 24.65 Million
- **2035:** $ 47.1 Million
- **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US)

**Report ID:** MRFR/HC/55140-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/italy-structural-heart-devices-market-56906

---

## Market Summary

## **Italy Structural Heart Devices Market Overview****:**

As per MRFR analysis, the Italy Structural Heart Devices Market Size was estimated at 19.88 (USD Million) in 2024.The Italy Structural Heart Devices Market Industry is expected to grow from 21.56(USD Million) in 2025 to 58.36 (USD Million) by 2035. The Italy Structural Heart Devices Market CAGR (growth rate) is expected to be around 9.475% during the forecast period (2025 - 2035).

### **Key Italy Structural Heart Devices Market Trends Highlighted**

The Italy Structural Heart Devices Market is experiencing notable trends driven by an increasing incidence of cardiovascular diseases among the aging population. The Italian government has been prioritizing healthcare spending to enhance the quality of medical devices, thus presenting a crucial driver for the market. As a result, healthcare institutions in Italy are investing in advanced structural heart device technologies that improve patient outcomes and streamline recovery processes. 

The country's aging demographic is particularly susceptible to heart conditions, driving demand for innovative solutions like transcatheter aortic valve replacement (TAVR) and septal occluders.Additionally, there are opportunities to be explored in the area of digital health integration within the structural heart landscape. The Ministry of Health in Italy is fostering a digital transformation in healthcare, promoting telemedicine and mobile health applications. 

This trend encourages the integration of smart devices that can facilitate remote monitoring and patient management, thus improving treatment adherence and follow-up care in the structural heart segment. In recent times, there has been a significant shift towards minimally invasive procedures, which not only reduce hospitalization time but also encourage a quicker return to daily activities.

The growing acceptance of these procedures among both medical professionals and patients highlights an emerging trend within the industry. Regulatory bodies in Italy are also adapting to these changes, launching streamlined approval pathways for innovative devices. Overall, the Italy Structural Heart Devices Market is set to evolve, driven by demographic challenges, technological advancements, and regulatory support, all of which define the current landscape of this vital segment of healthcare.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Italy Structural Heart Devices Market Drivers**

### **Aging Population in Italy**

The aging population in Italy is one of the most significant drivers of growth in the Italy Structural Heart Devices Market Industry. According to the Italian National Institute of Statistics, approximately 23% of the Italian population is over the age of 65, a number that is expected to rise significantly in the coming decades.

The prevalence of cardiovascular diseases increases with age, creating a higher demand for structural heart devices such as valve replacements and repair systems.Establishments like the Italian Society of Cardiology have emphasized the importance of addressing the needs of elderly patients, leading to increased healthcare investments aimed at improving treatments for aging individuals. Furthermore, as the population ages, there will be more emphasis on innovative medical technologies to treat complex heart conditions, thereby propelling the growth of the structural heart device market in Italy.

### **Increasing Incidence of Cardiovascular Diseases**

The increasing incidence of cardiovascular diseases in Italy serves as another significant market driver for the Italy Structural Heart Devices Market Industry. According to the WHO, cardiovascular diseases account for approximately 35% of all deaths in Italy, while a report from the Italian Ministry of Health indicates that over 900,000 people are diagnosed with heart disease annually.

This growing prevalence underscores the urgent need for effective treatment options, including structural heart devices.Key heart device industry vendors like Medtronic and Abbott are continuing to develop new technologies that help meet these challenges, improve patient outcomes, and increase the need for implantable devices in Italian hospitals.

### **Technological Advancements in Medical Devices**

Technological advancements in medical devices are driving the evolution within the Italy Structural Heart Devices Market Industry. Italian medical technology companies and research institutions are focusing on Research and Development (R&D) to innovate solutions. For instance, advances in minimally invasive surgical procedures have dramatically enhanced the appeal and success rates of structural heart interventions.

According to a report by the Italian Federation of Medical Device Industries (FIMMG), investments in innovative healthcare technologies have been increasing by roughly 7% per year.This increase not only improves patient outcomes but also attracts more healthcare providers to utilize advanced structural heart devices such as transcatheter aortic valve replacement systems, thus instigating growth in the market.

### **Supportive Government Policies and Funding**

Supportive government policies and funding are facilitating growth in the Italy Structural Heart Devices Market Industry. The Italian government has increased funding for healthcare initiatives, with approximately Euro 2 billion allocated for advanced medical technology in recent health budgets. Such funding aims to improve patient care and expand access to state-of-the-art treatments, thereby stimulating the demand for structural heart devices.

Initiatives by the Italian Ministry of Health to enhance cardiac care through partnerships with private and public entities further underscore this commitment.This proactive approach from the government offers incentives for innovation and implementation of new technologies, positioning Italy as a conducive environment for growth in the structural heart devices market.

## **Italy Structural Heart Devices Market Segment Insights****:**

### **Structural Heart Devices Market Type Insights**

The Italy Structural Heart Devices Market is multifaceted, showcasing various types of devices that cater to diverse medical needs. Among the key types, Heart Valve Devices stand out due to their essential role in treating heart valve diseases, often representing a significant portion of the market. These devices are designed to repair or replace malfunctioning heart valves, which is critical considering the aging population in Italy, where cardiovascular diseases are a primary health concern. Further diversifying the market, Annuloplasty Rings play a crucial role in surgical procedures aimed at correcting valve insufficiencies.

They ensure proper valve function, thereby improving patient outcomes. Given the rising prevalence of mitral valve disorders across Italy, the demand for reliable annuloplasty solutions is paramount.

Occluders are also instrumental in the treatment of structural heart issues, particularly congenital heart defects. These devices serve to close abnormal openings in the heart, contributing to effective patient recovery and management. As awareness of congenital heart disorders rises and more patients seek corrective options, occluders are becoming increasingly significant within the structural heart landscape.

Delivery Systems, while essential for the successful implementation of other structural heart devices, often take the backseat in discussions. However, these systems are crucial for the precise placement of devices, ensuring that procedures are both efficient and effective. Their importance is underscored by advancements in technology that have streamlined the delivery process, cementing their role in the successful treatment of structural heart conditions.

Overall, these device types illustrate a landscape that is not only growing but also evolving in response to specific healthcare needs in Italy. Factors such as ongoing Research and Development initiatives, an increase in cardiac procedures, and a comprehensive understanding of heart diseases continue to spur innovation and growth within the Italy Structural Heart Devices Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Structural Heart Devices Market Indication Insights**

The Italy Structural Heart Devices Market focuses on addressing critical cardiovascular conditions such as Valvular Heart Disease and Cardiomyopathy, which significantly impact the health and well-being of the population. Valvular Heart Disease, characterized by damage to one or more of the heart's four valves, presents a substantial challenge in Italy, with an increasing patient demographic necessitating advanced treatment options. 

The rising incidence of degenerative valve diseases drives demand for innovative interventions. On the other hand, Cardiomyopathy, a condition affecting the heart muscle and its ability to pump blood efficiently, is another major area of concern, particularly among younger populations due to genetic factors and lifestyle choices.The growing awareness of early detection and management of these diseases, along with advancements in technology, catalyzes market growth. Italy’s healthcare system is increasingly adopting minimally invasive procedures, further emphasizing the potential for medical devices that improve patient outcomes while reducing recovery times. 

Therefore, the understanding of these indications is crucial for enhancing the effectiveness and efficiency of Structural Heart Devices in the region. The combination of demographic shifts and evolving medical practices presents significant opportunities for innovation in this sector, solidifying its importance in the Italy Structural Heart Devices Market landscape.

### **Structural Heart Devices Market Procedure Insights**

The Procedure segment of the Italy Structural Heart Devices Market plays a crucial role in addressing various cardiac conditions, showcasing significant advancements in medical technology. This segment is primarily divided into Replacement Procedures and Repair Procedures, both of which cater to different patient needs and disease profiles. Replacement Procedures, which involve substituting damaged heart valves or structures, are essential for patients suffering from severe conditions, significantly improving their quality of life. 

Meanwhile, Repair Procedures focus on fixing existing structures, often leading to shorter recovery times and less invasive treatments.The growing prevalence of cardiovascular diseases in Italy, fueled by an aging population and lifestyle changes, is a major driver for this segment's growth. Additionally, advancements in minimally invasive techniques are reshaping the landscape, allowing for safer options and better outcomes for patients, contributing to the increasing adoption of these procedures. 

The Italy Structural Heart Devices Market revenue is bolstered by both segments, highlighting the importance of innovative solutions in the treatment of heart diseases. As the healthcare industry evolves, ongoing Research and Development efforts will likely continue to improve procedural efficacy and patient outcomes.

## **Italy Structural Heart Devices Market Key Players and Competitive Insights****:**

The Italy Structural Heart Devices Market is characterized by a dynamic environment driven by the demand for advanced medical solutions to treat cardiovascular conditions. The market presents a unique landscape filled with competitive strategies focusing on innovation, technology, and patient care. 

Major players are investing heavily in research and development to introduce state-of-the-art devices that can improve patient outcomes, minimize recovery times, and enhance procedural efficacy. This environment is further influenced by regulatory frameworks, healthcare policies, and rising patient awareness regarding minimally invasive procedures, all contributing to the evolving competitive scenario. As the healthcare sector transforms, the competitive insights into this market reveal a race among key players to establish a firm foothold through collaborations, mergers, and innovation, positioning themselves as leaders in this specialized sector.

Medtronic has established itself as a significant player in the Italy Structural Heart Devices Market with a comprehensive portfolio of leading-edge products targeted at treating structural heart diseases. Its strengths lie in a strong commitment to innovation and the robustness of its clinical research, enabling the company to deliver effective solutions such as transcatheter aortic valve replacement systems and left atrial appendage closure devices. Medtronic's extensive distribution channels and established relationships with healthcare providers across Italy facilitate its penetration in local markets.

Furthermore, their focus on state-of-the-art technology ensures they remain at the forefront of the industry, continuously refining their existing products while introducing new ones to meet the evolving demands of healthcare professionals and patients alike. 

The company's extensive experience in the field combined with a strategic approach to partnerships has fortified its market position, allowing Medtronic to maintain a strong competitive edge.AtriCure is another key player shaping the landscape of the Italy Structural Heart Devices Market with its specialized offerings aimed at atrial fibrillation treatment and associated structural heart conditions. The company has gained recognition for its innovative technologies, such as device systems designed for surgical ablation and hybrid procedures, which have proven effective in addressing complex cardiac challenges. 

AtriCure’s strong market presence in Italy is supported by its dedication to education and training for healthcare providers, ensuring that clinicians are well-equipped to utilize their devices effectively. The company's robust research initiatives and commitment to innovation allow it to maintain a significant competitive position, demonstrating effectiveness and safety in its interventions. 

AtriCure has also explored strategic mergers and collaborations that have expanded its capabilities and market reach within Italy, enhancing its portfolio and distribution network. Its focus on patient-centered solutions and commitment to advancing treatment protocols distinguishes AtriCure as a noteworthy competitor in the Italian market, dedicated to improving outcomes for patients with structural heart diseases.

### **Key Companies in the Italy Structural Heart Devices Market Include:**

- Medtronic
- AtriCure
- Cardiovascular Systems
- HeartWare International
- Cardiac Dimensions
- Boston Scientific
- Abbott
- Cameron Health
- St. Jude Medical
- Merit Medical Systems
- Sorin Group
- MitrAssist
- Edwards Lifesciences
- Terumo Corporation
- LivaNova

## **Italy Structural Heart Devices Market Industry Developments**

The Italy Structural Heart Devices Market has seen significant activity recently, with major companies such as Medtronic and Edwards Lifesciences leading the way in innovative product launches and advancements in technology. In September 2023, Medtronic unveiled new developments in their transcatheter heart valve therapies, aiming to broaden access to less invasive heart treatments in Italy. August 2023 was marked by increased collaboration between Abbott and local Italian healthcare providers to enhance the adoption of their latest structural heart solutions across the nation's hospitals. 

Additionally, the market has been positively impacted by growth in investment, as Cardiovascular Systems announced a strategic partnership with major Italian distributors to expand their reach in southern Europe. Over the past few years, the focus on minimally invasive procedures has fueled growth, with a reported increase in market valuation due to rising patient demands and advancements in technology. Notably, market consolidation has been evident, as Merger and Acquisition activity among firms like Boston Scientific and LivaNova hints at a more centralized market approach moving forward.

This dynamic environment positions Italy as an essential hub for structural heart device innovation and distribution in Europe.

## **Italy Structural Heart Devices Market Segmentation Insights**

### **Structural Heart Devices Market Type****Outlook**

- Heart Valve Devices
- Annuloplasty Rings
- Occluders
- Delivery Systems

### **Structural Heart Devices Market Indication****Outlook**

- Valvular Heart Disease
- Cardiomyopathy

### **Structural Heart Devices Market Procedure****Outlook**

- Replacement Procedures
- Repair Procedures
-  

## Market Drivers

### Growing Awareness and Education

The growing awareness and education surrounding cardiovascular health in Italy are pivotal in shaping the structural heart-devices market. Public health campaigns and initiatives aimed at educating the population about heart disease risks and prevention strategies have gained momentum. As individuals become more informed about the importance of early detection and treatment, the demand for structural heart devices is expected to rise. Healthcare professionals are also increasingly emphasizing the role of these devices in managing heart conditions, leading to greater acceptance among patients. Additionally, collaborations between medical institutions and educational organizations are fostering a culture of knowledge sharing, which may further enhance the understanding of structural heart devices. This heightened awareness is likely to translate into increased patient inquiries and referrals for these innovative solutions, thereby positively impacting market growth.

### Increased Healthcare Expenditure

The rising healthcare expenditure in Italy is a crucial factor propelling the structural heart-devices market. Recent reports indicate that healthcare spending in Italy has reached approximately €200 billion annually, with a significant portion allocated to cardiovascular care. This increase in funding allows for the procurement of advanced medical technologies, including structural heart devices, which are essential for treating complex heart conditions. Additionally, the Italian government has been investing in healthcare infrastructure, aiming to enhance the quality of care provided to patients. As hospitals and clinics upgrade their facilities and equipment, the demand for innovative structural heart devices is likely to grow. Furthermore, the emphasis on improving patient outcomes and reducing hospital readmission rates may lead to a greater focus on these devices, thereby driving market growth in the coming years.

### Technological Innovations in Device Design

Technological advancements in the design and functionality of structural heart devices are significantly influencing the market in Italy. Innovations such as minimally invasive procedures and enhanced imaging techniques are transforming how these devices are developed and utilized. For instance, the introduction of transcatheter aortic valve replacement (TAVR) has revolutionized treatment options for patients with aortic stenosis, leading to a surge in demand for such devices. The structural heart-devices market is expected to benefit from ongoing research and development efforts aimed at improving device efficacy and safety. Moreover, the integration of digital health technologies, such as remote monitoring and telemedicine, is likely to enhance patient management and follow-up care. As these innovations continue to emerge, they may drive further adoption of structural heart devices, ultimately contributing to market expansion in Italy.

### Regulatory Support for Innovative Therapies

Regulatory support for innovative therapies in Italy is emerging as a significant driver for the structural heart-devices market. The Italian Medicines Agency (AIFA) has been actively promoting the approval and reimbursement of novel medical devices, facilitating quicker access to advanced treatments for patients. This supportive regulatory environment encourages manufacturers to invest in research and development, leading to the introduction of cutting-edge structural heart devices. Moreover, streamlined approval processes may result in a broader range of options available to healthcare providers, enhancing patient care. As regulatory bodies continue to prioritize innovation, the structural heart-devices market is likely to experience accelerated growth. The collaboration between regulatory agencies and industry stakeholders may also foster a more dynamic market landscape, ultimately benefiting patients in need of these life-saving interventions.

### Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases in Italy is a primary driver for the structural heart-devices market. According to recent health statistics, cardiovascular diseases account for approximately 35% of all deaths in the country. This alarming trend necessitates advanced medical interventions, including structural heart devices, to manage and treat these conditions effectively. The demand for innovative solutions is further fueled by the aging population, which is more susceptible to heart-related ailments. As healthcare providers seek to improve patient outcomes, investments in structural heart devices are likely to rise, thereby expanding the market. Furthermore, the Italian healthcare system is increasingly prioritizing preventive care, which may lead to earlier interventions and a greater reliance on these devices. Consequently, the structural heart-devices market is poised for growth as healthcare professionals adapt to the evolving landscape of cardiovascular care.

## Future Outlook

The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) in Italy is projected to grow at a 6.69% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of minimally invasive surgical techniques for device implantation.
- Expansion of telehealth services for remote patient monitoring and follow-up.
- Partnerships with local hospitals for exclusive device distribution agreements.

By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovative heart solutions.

## Segment Insights

### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing)

In the Italy structural heart-devices market, the distribution of market share reveals that Transcatheter Aortic Valve Replacement accounts for the largest segment, followed by Mitral Valve Repair Devices, Left Atrial Appendage Closure Devices, and Transcatheter Pulmonary Valve. The established presence of TAVR in clinical settings contributes to its dominant position, while the growing awareness and adoption of minimally invasive techniques support the increasing demand for other innovative devices in the segment.

Growth trends indicate that the Mitral Valve Repair Devices are recognized as the fastest-growing segment, fueled by advancements in technology and a rising prevalence of mitral valve diseases. The demand for more effective and less invasive surgical options drives this growth. Additionally, Left Atrial Appendage Closure Devices are gaining traction due to their role in preventing stroke in atrial fibrillation patients, highlighting a shift towards preventative therapies in the market.

Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging)

Transcatheter Aortic Valve Replacement is positioned as the dominant technology within the Italy structural heart-devices market, known for its effective treatment of aortic stenosis and its proven clinical outcomes. It offers patients a less invasive alternative to traditional surgeries, which has resulted in widespread adoption among healthcare providers. In contrast, Mitral Valve Repair Devices represent an emerging technology, driven by a focus on treating mitral valve diseases through innovative techniques. These devices cater to a growing patient population and are favored for their capability to enhance patient recovery times and reduce hospital stays. The landscape is rapidly evolving as both technologies address critical heart conditions, with a strong emphasis on patient-centric solutions.

### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing)

In the Italy structural heart-devices market, the distribution among procedure types reveals that minimally invasive procedures dominate the landscape, holding a significant share of the market. Surgical procedures, while traditionally robust, are now being outpaced by percutaneous methods that are rapidly gaining traction due to their efficiency and lower recovery times. These dynamics create a competitive environment where innovation is vital for maintaining market relevance.

The growth trends in this segment highlight an increasing preference for minimally invasive techniques driven by advancements in technology and improved patient outcomes. As healthcare providers and patients seek less invasive options, the market responds with innovations in percutaneous devices, leading to surgical techniques becoming the fastest-growing procedure type. This shift is supported by ongoing research and development efforts aimed at enhancing efficacy and safety in heart procedures.

Minimally Invasive (Dominant) vs. Surgical (Emerging)

Minimally invasive procedures are characterized by smaller incisions and reduced trauma to the patient, leading to quicker recovery times and shorter hospital stays, making them the dominant choice in the Italy structural heart-devices market. Reviews indicate that patients prefer these options due to lesser pain and improved outcomes. In contrast, surgical procedures, while traditionally a mainstay in heart device implementations, are now being perceived as emerging due to the rising demand for alternatives that minimize surgical risks and hospital-associated complications. As both segments evolve, they reveal the necessity for continuous improvement and adaptation, ensuring that both minimally invasive and surgical procedures can meet future healthcare challenges while addressing patient needs.

### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing)

In the Italy structural heart-devices market, Aortic Stenosis leads the segment, commanding a significant share due to its prevalence among elderly populations. This condition contributes to the bulk of procedural interventions, establishing itself as the most addressed ailment. Mitral Regurgitation, on the other hand, has been gaining momentum as healthcare providers increasingly focus on innovative treatment options, leading to a swift rise in its market share.

Growth trends in this segment are heavily influenced by advancements in device technology and a surge in the aging demographic that suffers from these heart conditions. As clinical data supporting less invasive solutions becomes more robust, both Aortic Stenosis and Mitral Regurgitation are expected to see heightened demand. The increasing awareness regarding heart health and proactive patient management strategies further propel this segment's growth.

Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging)

Aortic Stenosis remains the dominant indication within the structural heart-devices market, characterized by a high number of surgical interventions and a range of treatment options, including transcatheter aortic valve replacements. Its prevalence necessitates ongoing innovation and investment in effective therapies. Conversely, Mitral Regurgitation is emerging rapidly, driven by the development of new device technologies and growing recognition of its treatment potential. As healthcare awareness increases, more patients are being diagnosed and treated for Mitral Regurgitation, thereby reshaping the market landscape. This shift indicates a pivot towards innovative approaches that cater to both indications, highlight the dynamic nature of evolving heart diseases, and the strategic focus of manufacturers to address unmet clinical needs.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Italy structural heart-devices market, hospitals hold the largest share among end users, reflecting their pivotal role in advanced medical procedures and patient care. Ambulatory surgical centers are rapidly gaining traction, driven by the need for cost-effective and efficient surgical solutions. Cardiology clinics, while essential, represent a smaller segment in comparison to these two dominant categories.

The growth trends within this segment are influenced by advancements in medical technology, an increasing prevalence of cardiovascular diseases, and a shift towards outpatient care models. The demand for minimally invasive procedures has bolstered the role of ambulatory surgical centers, while hospitals continue to expand their capabilities in structural heart interventions, leading to a dynamic healthcare landscape in Italy.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent the dominant end user in the Italy structural heart-devices market, characterized by their comprehensive range of services, access to advanced technologies, and skilled healthcare professionals. They are typically well-equipped to handle complex cardiac procedures, which significantly enhances patient outcomes. In contrast, ambulatory surgical centers are emerging as a popular alternative for patients seeking quicker procedures with shorter recovery times. These centers focus on efficiency and cost-effectiveness, reducing the overall burden on healthcare systems while addressing the growing demand for less invasive solutions. The rise of telemedicine and patient-centric care models further strengthens the position of ambulatory surgical centers, indicating a shift in patient preferences that hospitals must adapt to.

## Competitive Benchmarking

The structural heart-devices market in Italy is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Edwards Lifesciences (US) emphasizes its commitment to research and development, particularly in transcatheter heart valve technologies, which positions it favorably against competitors. Meanwhile, Medtronic (US) is leveraging its extensive portfolio and global reach to expand its offerings in structural heart solutions, indicating a strategy centered on comprehensive care. Abbott Laboratories (US) appears to be concentrating on digital health integration, which may enhance patient outcomes and streamline operations, thereby shaping the competitive environment significantly.
The market structure is moderately fragmented, with several key players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. This trend suggests a collective effort among major players to strengthen their operational capabilities while responding to regional demands. The influence of these companies is substantial, as they not only drive innovation but also set benchmarks for quality and service in the market.
In October 2025, Edwards Lifesciences (US) announced the launch of its next-generation transcatheter aortic valve replacement (TAVR) system, which is designed to improve patient outcomes through enhanced delivery mechanisms. This strategic move underscores the company's focus on innovation and its commitment to addressing the evolving needs of patients with aortic stenosis. The introduction of this advanced system is likely to reinforce Edwards' market leadership and attract a broader patient demographic.
In September 2025, Medtronic (US) expanded its partnership with a leading Italian healthcare provider to enhance access to its structural heart devices across the country. This collaboration aims to streamline the distribution of Medtronic's innovative products, thereby improving patient access to cutting-edge therapies. Such strategic alliances are indicative of Medtronic's approach to solidifying its market position while ensuring that its products reach a wider audience in Italy.
In August 2025, Abbott Laboratories (US) unveiled a new digital platform aimed at improving patient engagement and monitoring for those undergoing structural heart procedures. This initiative reflects Abbott's strategic focus on integrating technology into healthcare, potentially leading to better patient outcomes and increased satisfaction. By prioritizing digital health solutions, Abbott is likely to differentiate itself in a competitive market increasingly driven by technological advancements.
As of November 2025, the competitive trends in the structural heart-devices market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing operational efficiencies. The shift from price-based competition to a focus on technological innovation and supply chain reliability is becoming increasingly evident. Companies that prioritize these aspects are likely to gain a competitive edge, as the market evolves towards more sophisticated and patient-centric solutions.

## Recent News & Developments

The Italy Structural Heart Devices Market has seen significant activity recently, with major companies such as Medtronic and Edwards Lifesciences leading the way in innovative product launches and advancements in technology. In September 2023, Medtronic unveiled new developments in their transcatheter heart valve therapies, aiming to broaden access to less invasive heart treatments in Italy. August 2023 was marked by increased collaboration between Abbott and local Italian healthcare providers to enhance the adoption of their latest structural heart solutions across the nation's hospitals. 

Additionally, the market has been positively impacted by growth in investment, as Cardiovascular Systems announced a strategic partnership with major Italian distributors to expand their reach in southern Europe. Over the past few years, the focus on minimally invasive procedures has fueled growth, with a reported increase in market valuation due to rising patient demands and advancements in technology. Notably, market consolidation has been evident, as Merger and Acquisition activity among firms like Boston Scientific and LivaNova hints at a more centralized market approach moving forward.

This dynamic environment positions Italy as an essential hub for structural heart device innovation and distribution in Europe.

## Report Scope

| MARKET SIZE 2024 | 23.1(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 24.65(USD Million) |
| MARKET SIZE 2035 | 47.1(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.69% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) |
| Segments Covered | Type, Procedure Type, Indication, End User |
| Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the structural heart-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the structural heart-devices market in Italy. |
| Countries Covered | Italy |

## Frequently Asked Questions

**Q: What is the current valuation of the structural heart-devices market in Italy?**
A: The market valuation was $23.1 Million in 2024.

**Q: What is the projected market size for structural heart-devices in Italy by 2035?**
A: The projected valuation for 2035 is $47.1 Million.

**Q: What is the expected CAGR for the structural heart-devices market in Italy from 2025 to 2035?**
A: The expected CAGR during the forecast period is 6.69%.

**Q: Which companies are the key players in the Italy structural heart-devices market?**
A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific.

**Q: What are the main segments of the structural heart-devices market in Italy?**
A: The main segments include Transcatheter Aortic Valve Replacement, Mitral Valve Repair Devices, and Left Atrial Appendage Closure Devices.

**Q: How did the Transcatheter Aortic Valve Replacement segment perform in 2024?**
A: This segment had a valuation of $8.0 Million in 2024.

**Q: What is the projected valuation for Mitral Valve Repair Devices by 2035?**
A: The projected valuation for this segment is $12.0 Million by 2035.

**Q: What types of procedures are included in the structural heart-devices market?**
A: The market includes Minimally Invasive, Surgical, and Percutaneous procedures.

**Q: Which end users are driving the demand for structural heart-devices in Italy?**
A: Hospitals, Ambulatory Surgical Centers, and Cardiology Clinics are the primary end users.

**Q: What indications are addressed by the structural heart-devices market in Italy?**
A: The market addresses Aortic Stenosis, Mitral Regurgitation, Heart Failure, and Pulmonary Valve Stenosis.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/italy-structural-heart-devices-market-56906*